Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Reexamination Certificate
2000-05-25
2008-12-23
Padmanabhan, Sreeni (Department: 1617)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
C424S480000, C424S078070, C424S078240, C424S405000, C424S417000
Reexamination Certificate
active
07468194
ABSTRACT:
Disclosed in certain embodiments is a method of treating infections of an interior part of the human or animal body, comprising administering to said interior body part, a pharmaceutical preparation comprising a particulate carrier and an effective amount of an agent selected from the group consisting of an antiseptic agent, a wound-healing promoting agent and a combination thereof, to treat an infection at said interior body part.
REFERENCES:
patent: 2706701 (1955-04-01), Beller et al.
patent: 4113857 (1978-09-01), Shetty
patent: 4235871 (1980-11-01), Papahadjopoulous et al.
patent: 4560678 (1985-12-01), Ranson
patent: 4675009 (1987-06-01), Hymes et al.
patent: 4906476 (1990-03-01), Radhakrishnan
patent: 4938965 (1990-07-01), Shek et al.
patent: 5034228 (1991-07-01), Meybeck et al.
patent: 5049388 (1991-09-01), Knight et al.
patent: 5049389 (1991-09-01), Radhakrishnan
patent: 5114928 (1992-05-01), Gajdos et al.
patent: 5128139 (1992-07-01), Brown et al.
patent: 5232692 (1993-08-01), Isenberg et al.
patent: 5246708 (1993-09-01), von Borstel et al.
patent: 5290540 (1994-03-01), Prince et al.
patent: 5456923 (1995-10-01), Nakamichi et al.
patent: 5552158 (1996-09-01), Evans et al.
patent: 5863556 (1999-01-01), Ruckert et al.
patent: 5942245 (1999-08-01), Katinger et al.
patent: 0260241 (1988-03-01), None
patent: 0317405 (1989-05-01), None
patent: 0407028 (1991-01-01), None
patent: 0509338 (1992-10-01), None
patent: 0613685 (1994-09-01), None
patent: 06390373 (1995-02-01), None
patent: 1013269 (2000-06-01), None
patent: 63126820 (1988-05-01), None
patent: 2204413 (1990-08-01), None
patent: 7145081 (1995-06-01), None
patent: WO 85/00112 (1985-01-01), None
patent: 8809165 (1988-12-01), None
patent: 9011781 (1990-10-01), None
patent: 9324165 (1993-12-01), None
patent: 9414490 (1994-07-01), None
patent: 9422876 (1994-12-01), None
patent: 9614083 (1996-05-01), None
patent: 9960998 (1999-12-01), None
patent: 9960999 (1999-12-01), None
patent: 9961003 (1999-12-01), None
Hardman et al. “Goodman & Gilman's The Pharmacological Basis of Therapeutics” (9th ed, 1996) p. 51 and 57-58.
Raab W . Dermatologica, (1976) 152 Suppl 1, 67-79.
Abstract EP 0613685 (English), Sep. 7, 1994.
Abstract EP 0509338 (English), Oct. 21, 1992.
Janine F. Bridges, et al., “The Uptake of Liposome-Entrapped I-Labelled-Poly(Vinyl Pyrrolidone)By Rat Jejunum In-Vitro,” Biochemica et Biophycica Acta, 544 (1978) 448-451.
Peter M. Vogt, et al., “Polyvinyl pyrrolidone-iodine Lipsome Hydrogel Improves Epithelialization By Combing Moisture And Antisepsis. A New Concept In Wound Therapy,” Wound Repair and Regeneration vol. 9 No. 2 p. 116-122, Mar.-Apr. 2001.
Karen Reimer, et al., “An Innovative Topical Drug Formulation for Wound Healing And Infection Treatment: In-Vitro and In-Vivo Investigations of a Povidone-Iodine Liposome Hydrogel,” Dermatology 2000, 201: 235-241.
Janny Liautard, et al., “Encapsulation of Drugs Into Large Unilamellar Lipsomes Prepared by an Extemporaneous Method,” J. Microencapsulation, 1991, vol. 8, No. 3, 381-389.
Brian E. Gilbert, et al., “Aerosolized Liposomal Amphotericin B for Treatment of Pulmonary and Systemic Cryptococcus neoformans Infections in Mice,” Antimicrobial Agents and Chemotherapy, Jul. 1992, p. 1466-1471.
Brian E. Gilbert, et al., “Aerosolized Liposomal Amphotericin B for Treatment of Pulmonary and Systemic Cryptococcus neoformans Infections in Mice,” Antimicrobial Agents and Chemotherapy, Jul. 1992, p. 1466-1471.
P. Würzler, et al., “Virucidal and Chlamudicidal Activites of Povidone-Iodine(PVP-1)Lipsomes,” Clin Microbial Inf 5(suppl 3) 136 (1990) 9thEuropean Conference on Clin Microbiology and Infectious Diseases, Berlin, Mar. 1999.
Bernhard Müllinger, et al., “Coated Drug Droplets Allow Individual Dosimetry,” Respiratory Drug Delivery VI, Hilton Head, S.C. May 3-7, 1998, p. 385-387.
James F. Fitzgerald, et al., “Novel Coating For Improved Pulmonary Drug Delivery,” U. Of Florida Office of Graduate Research, Technology and Education, VF#1887, Jan. 15, 1998 (ABSTRACT).
David A. Edwards, et al., “Large Porous Particles for Pulmonary Drug Delivery,” Science, vol. 276, Jun. 20, 1997, p. 1868-1871.
H. Schreier, et al., “Formulation and in-vitro performance of liposome powder aerosols,” S.T.P. Pharma Sciences 4(1) 38-44, 1994.
Hans Schreier, et al., “Pulmonary delivery of liposomes,” Journal of Controlled Release, 24 (1993) 209-223.
Abstract JP 2204413 and JP 63126820 (English), 1988, May 30, 1998.
Xiaonan Cia, 1994, “The Clinical Use and Dosage Form of Iodophors”, Bulletin of the Medical School of Shantou University (2):77-89 (in Chinese and English).
Ganzer et al., 2001, Arthroskopie 14:31-44.
Fleischer Wolfgang
Reimer Karen
Euro-Celtique S.A.
Jones Day
Kantamneni Shobha
Padmanabhan Sreeni
LandOfFree
Preparations for the application of anti-inflammatory agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preparations for the application of anti-inflammatory agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparations for the application of anti-inflammatory agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4022132